This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Norbert Peekhaus: Innovator in Cancer Research
Introduction
Norbert Peekhaus is a prominent inventor based in Los Angeles, California. He has made significant contributions to the field of cancer research, particularly in the development of innovative therapeutic agents. His work focuses on targeting specific cancer cells to improve treatment outcomes.
Latest Patents
Norbert Peekhaus holds a patent for an "Immunotheranostic Agent Targeting Mesenchymal Stem Cell-Derived Cancer Cells and Mesenchymal Stem Cell Associated Disease." This patent represents a crucial advancement in the fight against cancer, offering new avenues for diagnosis and treatment.
Career Highlights
Peekhaus is affiliated with the University of California, where he conducts research and collaborates with other experts in the field. His dedication to advancing medical science has positioned him as a key figure in cancer research.
Collaborations
He has worked alongside notable colleagues such as Hans David Ulmert and Liqun Mao, contributing to a collaborative environment that fosters innovation and discovery.
Conclusion
Norbert Peekhaus exemplifies the spirit of innovation in the medical field, with his groundbreaking patent and collaborative efforts paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
